Concepedia

Mark Walzer

MW

11

Publications

459

Citations

10

H-Index

2002

Active since

Affiliations

Astellas Pharma (United States)(Current)

Lundbeck (United States)

Loyola University Chicago

Astellas Pharma (Netherlands)

Loyola University Medical Center

Mark Walzer is an author at Astellas Pharma (United States) specializing in medicine, pharmacology, and immunology.

Top concepts

Publications per year

2002–2021

11

Publications

11

Tau phosphorylation increases in symptomatic mice overexpressing A30P α-synuclein

Mark Frasier, Mark Walzer, Lois E. McCarthy et al. · Experimental Neurology · 2004 · 101 citations

, , +6

Neurotrophins support regenerative axon assembly over CSPGs by an ECM-integrin-independent mechanism

Feng‐Quan Zhou, Mark Walzer, Yao-Hong Wu et al. · Journal of Cell Science · 2006 · 99 citations · Full text

Pharmacokinetic Drug Interactions Between Clobazam and Drugs Metabolized by Cytochrome P450 Isoenzymes

Mark Walzer, Ihor Bekersky, Robert A. Blum et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2012 · 81 citations

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Aβ(25–35)-induced abnormal tau protein immunoreactivity in rat brain

Bertalan Dudás, Umberto Cornelli, J.M Lee et al. · Neurobiology of Aging · 2002 · 45 citations

, , +9

Low molecular weight glycosaminoglycan blockade of β-amyloid induced neuropathology

Mark Walzer, Stanley A. Lorens, Matthew J. Hejna et al. · European Journal of Pharmacology · 2002 · 37 citations

, , +5

Rows per page

1–5 of 11